BACKGROUND: Intimate partner violence (IPV) is prevalent among adolescent and adult women, with significant physical, sexual, and mental health consequences. In 2011, the Institute of Medicine's Clinical Preventive Services for Women consensus report recommended universal screening for violence as a component of women's preventive services; this policy has been adopted by the Health Resources and Services Administration (HRSA). These policy developments require that effective clinic-based interventions be identified, easily implemented, and taken to scale. METHODS: To foster dialogue about implementing effective interventions, we convened a symposium entitled "Responding to Violence Against Women: Emerging Evidence, Implementation Science, and Innovative Interventions," on May 21, 2012. Drawing on multidisciplinary expertise, the agenda integrated data on the prevalence and health impact of IPV violence, with an overview of the implementation science framework, and a panel of innovative IPV screening interventions. Recommendations were generated for developing, testing, and implementing clinic-based interventions to reduce violence and mitigate its health impact. RESULTS: The strength of evidence supporting specific IPV screening interventions has improved, but the optimal implementation and dissemination strategies are not clear. Implementation science, which seeks to close the evidence to program gap, is a useful framework for improving screening and intervention uptake and ensuring the translation of research findings into routine practice. CONCLUSIONS: Findings have substantial relevance to the broader research, clinical, and practitioner community. Our conference proceedings fill a timely gap in knowledge by informing practitioners as they strive to implement universal IPV screening and guiding researchers as they evaluate the success of implementing IPV interventions to improve women's health and well-being.
BACKGROUND: Intimate partner violence (IPV) is prevalent among adolescent and adult women, with significant physical, sexual, and mental health consequences. In 2011, the Institute of Medicine's Clinical Preventive Services for Women consensus report recommended universal screening for violence as a component of women's preventive services; this policy has been adopted by the Health Resources and Services Administration (HRSA). These policy developments require that effective clinic-based interventions be identified, easily implemented, and taken to scale. METHODS: To foster dialogue about implementing effective interventions, we convened a symposium entitled "Responding to Violence Against Women: Emerging Evidence, Implementation Science, and Innovative Interventions," on May 21, 2012. Drawing on multidisciplinary expertise, the agenda integrated data on the prevalence and health impact of IPV violence, with an overview of the implementation science framework, and a panel of innovative IPV screening interventions. Recommendations were generated for developing, testing, and implementing clinic-based interventions to reduce violence and mitigate its health impact. RESULTS: The strength of evidence supporting specific IPV screening interventions has improved, but the optimal implementation and dissemination strategies are not clear. Implementation science, which seeks to close the evidence to program gap, is a useful framework for improving screening and intervention uptake and ensuring the translation of research findings into routine practice. CONCLUSIONS: Findings have substantial relevance to the broader research, clinical, and practitioner community. Our conference proceedings fill a timely gap in knowledge by informing practitioners as they strive to implement universal IPV screening and guiding researchers as they evaluate the success of implementing IPV interventions to improve women's health and well-being.
Authors: Suzanne Maman; Jessie K Mbwambo; Nora M Hogan; Gad P Kilonzo; Jacquelyn C Campbell; Ellen Weiss; Michael D Sweat Journal: Am J Public Health Date: 2002-08 Impact factor: 9.308
Authors: Ann L Coker; Keith E Davis; Ileana Arias; Sujata Desai; Maureen Sanderson; Heather M Brandt; Paige H Smith Journal: Am J Prev Med Date: 2002-11 Impact factor: 5.043
Authors: Joanne Klevens; Romina Kee; William Trick; Diana Garcia; Francisco R Angulo; Robin Jones; Laura S Sadowski Journal: JAMA Date: 2012-08-15 Impact factor: 56.272
Authors: Katherine M Iverson; Omonyêlé Adjognon; Alessandra R Grillo; Melissa E Dichter; Cassidy A Gutner; Alison B Hamilton; Shannon Wiltsey Stirman; Megan R Gerber Journal: J Gen Intern Med Date: 2019-08-16 Impact factor: 5.128
Authors: Traci Kazmerski; Heather L McCauley; Kelley Jones; Sonya Borrero; Jay G Silverman; Michele R Decker; Daniel Tancredi; Elizabeth Miller Journal: Matern Child Health J Date: 2015-07
Authors: Elizabeth Miller; Heather L McCauley; Michele R Decker; Rebecca Levenson; Sarah Zelazny; Kelley A Jones; Heather Anderson; Jay G Silverman Journal: Perspect Sex Reprod Health Date: 2017-03-08
Authors: Elizabeth Miller; Daniel J Tancredi; Michele R Decker; Heather L McCauley; Kelley A Jones; Heather Anderson; Lisa James; Jay G Silverman Journal: Contraception Date: 2016-02-15 Impact factor: 3.375
Authors: Judith Wuest; Marilyn Merritt-Gray; Norma Dubé; Marilyn J Hodgins; Jeannie Malcolm; Jo Ann Majerovich; Kelly Scott-Storey; Marilyn Ford-Gilboe; Colleen Varcoe Journal: Res Nurs Health Date: 2015-01-12 Impact factor: 2.228
Authors: Daniel J Tancredi; Jay G Silverman; Michele R Decker; Heather L McCauley; Heather A Anderson; Kelley A Jones; Samantha Ciaravino; Angela Hicks; Claire Raible; Sarah Zelazny; Lisa James; Elizabeth Miller Journal: BMC Womens Health Date: 2015-08-06 Impact factor: 2.809